Emmanuel Macron weiht das Exzellenzlabor von EssilorLuxottica ein

The Labex boasts the capacity to deliver up to 20,000 corrective lenses per day. With a team of three hundred skilled professionals at full capacity, it is set to increase the production of prescription lenses in France by forty percent, with a significant expansion of the range of products with Origine France Garantie certification. The facility will serve as a key pillar of ophthalmic manufacturing within the country, better addressing the needs of the French consumer and the growing demand for vision care. In line with its commitment, EssilorLuxottica is coordinating the Premyom research consortium on myopia control solutions, part of the “France 2030” plan.

With 16 000 m² housing 104 manufacturing machines, of which the majority operate with in-house state-of-the art technologies, and processes enhanced by automation and AI, this facility also allows visitors to experience the Group's innovations, technologies and iconic brands. Strategically located near the group's Innovation & Technology Center in Créteil, the Labex fosters seamless collaboration and rapid deployment of future innovations and new categories. It houses production lines for high-tech lenses under iconic brands such as Varilux, Transitions, and Stellest, as well as an edging-mounting activity ensuring the timely delivery of complete-pair equipment: frames fitted with corrective lenses.